查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1405855

美國磁振造影血管攝影 (MRA) 市場規模、佔有率、趨勢分析報告：按技術、適應症、最終用途和細分市場預測，2023-2030 年

U.S. Magnetic Resonance Angiography Market Size, Share & Trends Analysis Report By Technique (Contrast Enhanced MRA, Non-contrast Enhanced MRA), By Indication, By End-use, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

美國磁振造影血管攝影 (MRA) 市場成長與趨勢：

Grand View Research, Inc最新報告顯示，到2030年，美國磁振造影血管攝影（MRA）市場規模預計將達到29.3億美元，2023年至2030年成像技術年成長率為2.9%。增強人工智慧（AI）在市場中不斷成長，預計將在預測期內為市場成長做出貢獻。

人工智慧可以幫助檢測腫瘤等異常生長。自動檢測透過快速報告改善了患者的整體體驗。

在美國，大約十分之四的成年人患有至少一種慢性病，約佔總人口的 45%。此外，不斷成長的老年人口正在增加需要更好診斷的慢性疾病的盛行率，並且對包括磁振造影血管攝影（MRA）在內的診斷影像的需求預計將會增加。在美國，廣泛的私人和公共融資措施的存在可能有助於市場成長。 Medicare 承保您的醫療保健提供者為您進行的 MRI 掃描，作為您醫療診斷的一部分。

有些患者會出現恐懼症恐懼症，出於恐懼而避免核磁共振造影系統。飛利浦、西門子和日立主要企業都為患有恐懼症的患者推出了採用開孔設計的設備。此外，這些公司還提供允許患者在設備內獲得音訊體驗的設備，以幫助他們放鬆並接受測試。與 CT 機不同， 核磁共振造影系統在診斷過程中不使用輻射。因此，未來幾年對 MRI 和 MRA 的需求預計將成長。

美國磁振造影血管攝影 (MRA) 市場報告亮點

  • 從技術造影MRA 在 2022 年的銷售中佔據主導地位，因為它被認為對孕婦和腎病患者來說是更安全的選擇。
  • 造影MRA 片段預計將在預測期內創下最快的複合年成長率，因為它提供了血管與其周圍組織和器官相比的詳細圖像。
  • 腹部 MRA 領域預計 2023 年至 2030 年將創下最高複合年成長率。腹部 MRA 可幫助評估和診斷各種血管異常，檢查淋巴結、血管和血流，並確定腫脹和疼痛的原因。
  • 按最終用途分類，由於對負擔得起的診斷服務的需求不斷成長，醫院細分市場在 2022 年的收益方面佔據主導地位。預計 2023 年至 2030 年，影像中心領域的複合年成長率將達到最快。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章美國磁振造影血管攝影 (MRA) 市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 普及和成長前景圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 美國磁振造影血管攝影（MRA）市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章美國磁振造影血管攝影（MRA）市場：技術評估與趨勢分析

  • 美國磁振造影血管攝影 (MRA) 市場：重點
  • 美國磁振造影血管攝影 (MRA) 市場：2022 年和 2030 年技術趨勢和市場佔有率分析
  • 造影造影血管攝影
  • 非造影MRA

第5章美國磁振造影血管攝影（MRA）市場：適應症估計與趨勢分析

  • 美國磁振造影血管攝影 (MRA) 市場：重點
  • 美國磁振造影血管攝影 (MRA) 市場：2022 年和 2030 年適應症趨勢和市場佔有率分析
  • 腹部
  • 下肢
  • 其他

第6章美國磁振造影血管攝影（MRA）市場：最終用途估計與趨勢分析

  • 美國磁振造影血管攝影 (MRA) 市場：重點
  • 美國磁振造影血管攝影 (MRA) 市場：2022 年和 2030 年最終用途趨勢和市場佔有率分析
  • 醫院
  • 形像中心
  • 門診手術中心及其他醫療機構

第7章競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 市場參與企業分類
    • GE Healthcare
    • Koninklijke Philips NV
    • Siemens Healthcare GmbH
    • Hitachi, Ltd.
    • Canon, Inc.
    • Shenzhen Anke Hi-Tech Co., Ltd.
    • Time Medical Holding
    • ASG Superconductors SpA
    • Neusoft Corporation
    • Shimadzu Corporation
    • ESAOTE SpA
    • AllTech Medical Systems
    • CentraCare
    • Radiology Associates of Ocala
    • Hunt Regional Healthcare
    • Montgomery Radiology Associates
Product Code: GVR-4-68038-769-8

U.S. Magnetic Resonance Angiography Market Growth & Trends:

The U.S. magnetic resonance angiography market size is expected to reach USD 2.93 billion by 2030, based on a new report by Grand View Research, Inc., expanding at a CAGR of 2.9% from 2023 to 2030 Rising adoption of artificial intelligence (AI) based imaging techniques is expected to contribute to market growth over the forecast period. AI can assist in the detection of abnormal growths, such as tumors. Automatic detection improves the overall patient experience due to faster reporting.

In U.S., around four in ten adults suffer from at least one chronic disease, accounting for around 45% of the total population. Moreover, growing elderly population has given rise to a higher incidence rate of chronic diseases needing better diagnosis, which is anticipated to drive the demand for diagnostic imaging procedures, including magnetic resonance angiography (MRA), in the country. The presence of extensive private and public funding initiatives in U.S. is likely to contribute to market growth. Medicare covers MRI scans ordered by healthcare providers as part of a medical diagnosis.

Some of the patients experience anxiety due to claustrophobia and avoid MRI machines due to fear. Key players such as Philips, Siemens, and Hitachi have launched open bore designs for patients suffering from fear of enclosed spaces. In addition, these companies are offering devices with an audiovisual experience inside the machine to help patients relax while undergoing the procedures. MRI machines use no radiations while diagnosis, unlike CT machines. Hence, demand for MRI and MRA procedures is expected to grow over the coming years.

U.S. Magnetic Resonance Angiography Market Report Highlights:

  • By technique, the non-contrast enhanced magnetic resonance angiography segment dominated the market in 2022 in terms of revenue as it is considered to be a safer alternative for patients who are pregnant or are suffering from kidney disorders
  • The contrast enhanced MRA segment is expected to register the fastest CAGR over the forecast period as they offer a detailed image of the blood vessels as compared to the tissues or organs surrounding them
  • The abdominal MRAs segment is expected to register a maximum CAGR from 2023 to 2030. Abdominal MRAs assist in the assessment and diagnosis of various vascular abnormalities and are performed for the examination of the lymph nodes, blood vessels, blood flow, and to investigate the cause of swelling or pain
  • By end use, the hospitals segment dominated the market in 2022 in terms of revenue on account of increased demand for affordable diagnostic services. The imaging centers segment is expected to register the fastest CAGR from 2023 to 2030.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Technique
    • 1.1.2. Indication
    • 1.1.3. End-use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Technique outlook
    • 2.2.2. Indication outlook
    • 2.2.3. End-use outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Magnetic Resonance Angiography Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. U.S. Magnetic Resonance Angiography Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's Five Forces
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic Landscape

Chapter 4. U.S. Magnetic Resonance Angiography Market: Technique Estimates & Trend Analysis

  • 4.1. U.S. Magnetic Resonance Angiography Market: Key Takeaways
  • 4.2. U.S. Magnetic Resonance Angiography Market: Technique Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Contrast-Enhanced MRA
    • 4.3.1. Contrast-Enhanced MRA market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Non-contrast Enhanced MRA
    • 4.4.1. Non-contrast Enhanced MRA market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. U.S. Magnetic Resonance Angiography Market: Indication Estimates & Trend Analysis

  • 5.1. U.S. Magnetic Resonance Angiography Market: Key Takeaways
  • 5.2. U.S. Magnetic Resonance Angiography Market: Indication Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Abdomen
    • 5.3.1. Abdomen market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Lower Extremities
    • 5.4.1. Lower extremities market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. U.S. Magnetic Resonance Angiography Market: End-use Estimates & Trend Analysis

  • 6.1. U.S. Magnetic Resonance Angiography Market: Key Takeaways
  • 6.2. U.S. Magnetic Resonance Angiography Market: End-use Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Hospitals
    • 6.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Imaging Centers
    • 6.4.1. Imaging centers market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Ambulatory Surgical Centers and Other Healthcare Settings
    • 6.5.1. Ambulatory Surgical Centers and Other Healthcare Settings market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. GE Healthcare
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Koninklijke Philips N.V.
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Siemens Healthcare GmbH
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Hitachi, Ltd.
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Canon, Inc.
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Shenzhen Anke Hi-Tech Co., Ltd.
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Time Medical Holding
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. ASG Superconductors SpA
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. Neusoft Corporation
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. Shimadzu Corporation
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives
    • 7.2.11. ESAOTE SpA
      • 7.2.11.1. Company overview
      • 7.2.11.2. Financial performance
      • 7.2.11.3. Product benchmarking
      • 7.2.11.4. Strategic initiatives
    • 7.2.12. AllTech Medical Systems
      • 7.2.12.1. Company overview
      • 7.2.12.2. Financial performance
      • 7.2.12.3. Product benchmarking
      • 7.2.12.4. Strategic initiatives
    • 7.2.13. CentraCare
      • 7.2.13.1. Company overview
      • 7.2.13.2. Financial performance
      • 7.2.13.3. Product benchmarking
      • 7.2.13.4. Strategic initiatives
    • 7.2.14. Radiology Associates of Ocala
      • 7.2.14.1. Company overview
      • 7.2.14.2. Financial performance
      • 7.2.14.3. Product benchmarking
      • 7.2.14.4. Strategic initiatives
    • 7.2.15. Hunt Regional Healthcare
      • 7.2.15.1. Company overview
      • 7.2.15.2. Financial performance
      • 7.2.15.3. Product benchmarking
      • 7.2.15.4. Strategic initiatives
    • 7.2.16. Montgomery Radiology Associates
      • 7.2.16.1. Company overview
      • 7.2.16.2. Financial performance
      • 7.2.16.3. Product benchmarking
      • 7.2.16.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 U.S. magnetic resonance angiography market, by technique, 2018 - 2030 (USD Million)
  • Table 3 U.S. magnetic resonance angiography market, by indication, 2018 - 2030 (USD Million)
  • Table 4 U.S. magnetic resonance angiography market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 U.S. magnetic resonance angiography: market outlook
  • Fig. 9 U.S. Magnetic Resonance Angiography Competitive Insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 U.S. Magnetic Resonance Angiography Market Driver Impact
  • Fig. 15 U.S. magnetic resonance angiography market restraint impact
  • Fig. 16 U.S. Magnetic Resonance Angiography Market Strategic Initiatives Analysis
  • Fig. 17 U.S. magnetic resonance angiography market: Technique movement analysis
  • Fig. 18 U.S. magnetic resonance angiography market: Technique outlook and key takeaways
  • Fig. 19 Contrast enhanced MRA market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Non-contrast enhanced MRA market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 U.S. magnetic resonance angiography market: Indication movement analysis
  • Fig. 22 U.S. magnetic resonance angiography market: Indication outlook and key takeaways
  • Fig. 23 Abdomen market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Lower extremities market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 U.S. magnetic resonance angiography market: End-use movement analysis
  • Fig. 27 U.S. magnetic resonance angiography market: End-use outlook and key takeaways
  • Fig. 28 Hospital market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Imaging centers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Ambulatory surgical centers & other healthcare settings market estimates and forecasts, 2018 - 2030 (USD Million)